首页> 外文期刊>Journal of the American Chemical Society >Streamlined Process for the Chemical Synthesis of RNA Using 2'-O-Thionocarbamate-Protected Nucleoside Phosphoramidites in the Solid Phase
【24h】

Streamlined Process for the Chemical Synthesis of RNA Using 2'-O-Thionocarbamate-Protected Nucleoside Phosphoramidites in the Solid Phase

机译:使用2'-O-硫代氨基甲酸酯保护的核苷亚磷酰胺固相化学合成RNA的简化方法

获取原文
获取原文并翻译 | 示例
       

摘要

An improved method for the chemical synthesis of RNA was developed utilizing a streamlined method for the preparation of phosphoramidite monomers and a single-step deprotection of the resulting oligoribonudeotide product using 1,2-diamines under anhydrous conditions. The process is compatible with most standard heterobase protection and employs "' a 2'-O-(l,l-dioxo-lA~6-thiomorpholine-4-carbothioate) as a unique 2'-hydroxyl protective group. Using this approach, it was demonstrated that the chemical synthesis of RNA can be as simple and robust as the chemical synthesis of DNA.
机译:利用流线型方法制备亚磷酰胺单体,并在无水条件下使用1,2-二胺对所得的寡核糖核苷酸产物进行单步脱保护,从而开发出一种改进的RNA化学合成方法。该方法与大多数标准杂碱保护均兼容,并采用了2'-O-(1,1-二氧代-1A〜6-巯基吗啉-4-羰基硫代酸酯)作为独特的2'-羟基保护基。事实证明,RNA的化学合成与DNA的化学合成一样简​​单且稳定。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2011年第30期|p.11540-11556|共17页
  • 作者单位

    Agilent Laboratories, Agilent Technologies, Inc., 5301 Stevens Creek Boulevard, Santa Clara, California 95051, United States;

    Agilent Laboratories, Agilent Technologies, Inc., 5301 Stevens Creek Boulevard, Santa Clara, California 95051, United States,These authors contributed equally to this work.;

    Agilent Laboratories, Agilent Technologies, Inc., 5301 Stevens Creek Boulevard, Santa Clara, California 95051, United States,These authors contributed equally to this work.;

    These authors contributed equally to this work.,Agilent Nucleic Acids Solutions Division, 5555 Airport Boulevard, Suite 100, Boulder, Colorado 80301, United States;

    Agilent Laboratories, Agilent Technologies, Inc., 5301 Stevens Creek Boulevard, Santa Clara, California 95051, United States,Department of Medical Chemistry, University of Szeged, Hungary;

    Agilent Laboratories, Agilent Technologies, Inc., 5301 Stevens Creek Boulevard, Santa Clara, California 95051, United States;

    These authors contributed equally to this work.,Noxxon Pharma AG, Berlin, Germany;

    Agilent Laboratories, Agilent Technologies, Inc., 5301 Stevens Creek Boulevard, Santa Clara, California 95051, United States;

    Agilent Nucleic Acids Solutions Division, 5555 Airport Boulevard, Suite 100, Boulder, Colorado 80301, United States;

    Agilent Nucleic Acids Solutions Division, 5555 Airport Boulevard, Suite 100, Boulder, Colorado 80301, United States;

    Agilent Laboratories, Agilent Technologies, Inc., 5301 Stevens Creek Boulevard, Santa Clara, California 95051, United States;

    Agilent Nucleic Acids Solutions Division, 5555 Airport Boulevard, Suite 100, Boulder, Colorado 80301, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:14:23

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号